Arpeggio Biosciences

Arpeggio Biosciences

A a biotechnology company developing a drug-screening platform for the acceleration of drug discovery by combining custom laboratory assay and proprietary machine learning algorithms.

All edits by  Mitchell Duffy 

Edits on 19 Aug 2019
Mitchell Duffy
Mitchell Duffy edited on 19 Aug 2019 8:40 am
Edits made to:
Article (+15/-23 characters)


The companies drug screening platform is can be used by scientists performing research related to dugdrug discovery and the mechanisms of actionsaction underlying the effectiveness of drugs. The drug screening platform provides time series profiling of drug compounds using RNA-profiling technology to gain insight into how thousands of genes are interacting within the human body. The company thanthen uses machine learning algorithms to analyze the time series profile to discover causal signalling networks, which can give researchers insight into the underlying mechanisms of action for their drugs, and help them predict about how a certain drug will affect a patient. 

No more activity to show.